Skip to main content

Table 2 Study of plasma fasting blood sugar (FBS), serum insulin, and resistance (HOMA-IR) in control and experimental groups

From: Potential prophylactic effect of chemical chaperones for alleviation of endoplasmic reticulum stress in experimental diabetic cataract

Groups

FBS mg/dl

Insulin μIU/ml

HOMA-IR

Group 1: control

 Range

7.9–99

20–32.5

3.9–7.3

 Mean ± S.D

88.6 ± 7.14

24.84 ± 4.92

5.37 ± 1.04

Group 2: diabetic model

 Range

200–286

12–22.5

6.2–13.8

 Mean ± S.D

231.6 ± 25.84a

16.57 ± 3.73a

9.46 ± 2.33a

Group 3: diabetic model + 4PBA

 Range

145–185

11.27–22.5

4–9.7

 Mean ± S.D

164.53 ± 11.71a,b

17.17 ± 4.06a

6.9 ± 1.8a,b

Group 4: diabetic model + TUDCA

 Range

148–187

12.5–30.1

4.9–13.3

 Mean ± S.D

168.53 ± 14.67a,b

19.42 ± 5.28a

8.1 ± 2.45a

Group 5: diabetic model + TMAO

 Range

164–232

11.3–27.5

5.1–12.8

 Mean ± S.D

198.53 ± 24.21a,b

18.28 ± 4.7a

8.94 ± 2.55a

  1. SD standard deviation. n = 15
  2. aSignificant in comparing with control group at P < 0.05
  3. bSignificant in comparing with diabetic model group at P < 0.05